Subject(s)
Fluorodeoxyglucose F18 , Lymphoma, Large B-Cell, Diffuse , Humans , Positron Emission Tomography Computed Tomography , Lymphoma, Large B-Cell, Diffuse/complications , Lymphoma, Large B-Cell, Diffuse/diagnostic imaging , Lymphoma, Large B-Cell, Diffuse/pathology , Radiopharmaceuticals , Peritoneum , Positron-Emission TomographyABSTRACT
18Fluorine-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) plays a pivotal role in the staging, restaging, and surveillance of various bone tumors, including plasmacytomas and osteosarcomas. Solitary plasmacytomas most frequently occur in the bones and are primarily treated with either surgery or radiotherapy. Radiation-induced osteosarcomas (RIOS) usually develop after a median interval of 11 years between radiation and sarcoma presentation. However, these can rarely present with a short latent period of 4 years or even lesser. In such cases, whole-body imaging plays a vital role in the early detection and management of RIOS. Herein, we present the case of a 29-year-old female patient with solitary plasmacytoma undergoing a follow-up whole-body 18F-FDG PET/CT, which revealed metastatic RIOS after a short latent period.
ABSTRACT
Tumour thrombus is an uncommon complication with ominous outcomes. F18 FDG PET-CT scan helps in differentiating tumour thrombus from venous thrombus owing to its metabolic uptake similar to the tumour. We discuss an interesting case of gastric malignancy with complete splenic vein tumour thrombosis on initial presentation.
Subject(s)
Stomach Neoplasms , Thrombosis , Fluorodeoxyglucose F18 , Humans , Positron Emission Tomography Computed Tomography , Positron-Emission Tomography , Radiopharmaceuticals , Splenic Vein/diagnostic imaging , Stomach Neoplasms/complications , Stomach Neoplasms/diagnostic imaging , Tomography, X-Ray ComputedABSTRACT
Breast cancer is the most common etiology of leptomeningeal carcinomatosis (LC), with or without brain parenchymal involvement. However, only 5% of patients with breast cancer develop leptomeningeal metastasis even in late clinical course. It can rarely be detected on bone scintigraphy. MRI is the modality of choice.
Subject(s)
Breast Neoplasms , Juglans , Meningeal Carcinomatosis , Humans , Magnetic Resonance ImagingABSTRACT
The synergy of the anatomic-metabolic details provided by PET-CT plays a substantial role in the diagnostic workup of Pyrexia of Unknown Origin (PUO). Although several imaging modalities have been used in the detection of cause of PUO, PET-CT is the most sensitive and specific modality for detection of cause. RCC is a rare cause of PUO.
Subject(s)
Carcinoma, Renal Cell/diagnostic imaging , Fever of Unknown Origin/etiology , Kidney Neoplasms/diagnostic imaging , Adult , Blood Sedimentation , C-Reactive Protein , Carcinoma, Renal Cell/blood , Carcinoma, Renal Cell/complications , Carcinoma, Renal Cell/surgery , Fever of Unknown Origin/blood , Fluorodeoxyglucose F18 , Humans , Kidney Neoplasms/blood , Kidney Neoplasms/complications , Kidney Neoplasms/surgery , Male , Nephrectomy , Positron Emission Tomography Computed Tomography , Radiopharmaceuticals , UltrasonographyABSTRACT
Renal cell carcinoma (RCC) is the most common solid renal malignancy that metastasizes typically to lungs, bones, liver, adrenals, and lymph nodes. Isolated pleural metastases of RCC are extremely rare, with only few cases reported in the literature. We report one such case of a 60-year-old woman, a known case of RCC of the left kidney who underwent nephrectomy, and on follow-up, PET/CT scan revealed diffuse thick nodular hypermetabolic left pleural thickening, which was later biopsied and turned out to be pleural metastases from RCC. No other site of metastases was found.
Subject(s)
Carcinoma, Renal Cell/diagnostic imaging , Kidney Neoplasms/diagnostic imaging , Pleural Neoplasms/diagnostic imaging , Positron Emission Tomography Computed Tomography , Adult , Carcinoma, Renal Cell/pathology , Gallium Isotopes , Gallium Radioisotopes , Humans , Kidney Neoplasms/pathology , Male , Membrane Glycoproteins , Organometallic Compounds , Pleural Neoplasms/secondary , RadiopharmaceuticalsABSTRACT
Bone metastases in HCC are uncommon with an incidence of 3% to 20%. Screening for bone metastasis is not a routine practice. Diagnosis is often delayed, and usually made once symptoms develop.